drugset / Trial / NCT00687531

Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)

NCT00687531

Phase 4 Terminated 385 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Open label, 12-week clinical trial to assess efficacy, safety, treatment adherence and Quality of Life impact of Mometasone Furoate dry powder 400 mcg once-daily in persistent mild-moderate asthmatic patients at least 12 years old. Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.

Timeline

Start
2006-11
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 400 ug

Indications